PowerVision said in a regulatory filing that it has obtained $12.5 million in a funding round. The Belmont, Calif.-based company will use the proceeds to finance research and development as well as clinical studies to back its efforts to obtain European market clearance for its intraocular lens implants.

Related Summaries